Ekso Bionics Holdings, Inc. announced a new randomized comparative clinical trial is currently underway in Europe. The trial is called "The MOST Study" (Mobility improved after stroke when a robotic device was used in comparison to physical therapy). This study is investigating the impact of gait training with the Ekso GT(TM) on functional independence of 80 patients with impaired gait as a consequence of stroke, when compared to conventional physiotherapy alone.

Early observations from clinical use of Ekso GT for rehabilitation of stroke patients at Moritz Klinik led to the development of the MOST study. In this study the Ekso GT will be used daily in one group, while in the control group patients will be treated with conventional physiotherapy alone, in a daily training program, over the course of three weeks. The level of functional mobility will then be compared between both groups.

The study is scheduled to conclude mid-year 2017.